Screening for osteoporosis among postmenopausal women in community pharmacy
Fuente:
Redalyc
Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Centro de investigaciones y Publicaciones Farmacéuticas
2006
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1876428353327595520 |
|---|---|
| author | Damià Barris Blundell |
| author_facet | Damià Barris Blundell |
| contents | Screening for osteoporosis among postmenopausal women in community pharmacy Damià Barris Blundell Carmen Rodríguez Zarzuelo Belén Sabio Sánchez José Luis Gutiérrez Álvarez Elena Navarro Visa Óscar Muñoz Valdés Belén Garrido Jiménez Rocío Sánchez Gómez Medicina Spain Osteopenia Osteoporosis Mass screening Ultrasonography Objectives: To identify postmenopausal women withrisk of osteoporosis through quantitative ultrasoundimaging (QUI) and to value the medical interventionafter the determination of the bone mineral density(BMD).Methods: Cross-sectional descriptive studydeveloped in a community pharmacy. During themonth of June of 2005 the community pharmacyenrolled postmenopausal women into the study.Women in treatment with calcium, vitamin D,hormone replacement therapy, estrogen receptormodulators, calcitonin or biphosphonates wereconsidered criteria for exclusion. To all the womenthat consent to participate, the pharmacistmeasured BMD with the device Sahara HologicUltrasound Bone Densitometer at right calcaneus.Following the World Health Organization, womenwere classified as osteoporotic if their T-Score wasless than -2.5 and as osteopenic if their T-Scoreranged between -2.5 and -1.0.Results: Of the 100 women screened, 11 (11%)presented risk of osteoporosis and 61 (61%) ofosteopenia. The 18.5% postmenopausal womenwith body mass index lesser than 30 presented riskof osteoporosis and the 63.0% osteopenia.Conclusions: The QUI constitutes a useful tool incommunity pharmacy for the screening ofosteoporosis and it supposes a greater integrationof the community pharmacy within the health care. 2006 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69040208 https://www.redalyc.org/journal/690/69040208/ https://www.redalyc.org/journal/690/69040208/html/ https://www.redalyc.org/journal/690/69040208/69040208.epub https://www.redalyc.org/journal/690/69040208/movil en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.2 Vol.4 |
| format | Artículo científico |
| id | redalyc_69040208 |
| institution | Redalyc |
| language | en |
| publishDate | 2006 |
| publisher | Centro de investigaciones y Publicaciones Farmacéuticas |
| spellingShingle | Screening for osteoporosis among postmenopausal women in community pharmacy Damià Barris Blundell Medicina Spain Osteopenia Osteoporosis Mass screening Ultrasonography Screening for osteoporosis among postmenopausal women in community pharmacy Damià Barris Blundell Carmen Rodríguez Zarzuelo Belén Sabio Sánchez José Luis Gutiérrez Álvarez Elena Navarro Visa Óscar Muñoz Valdés Belén Garrido Jiménez Rocío Sánchez Gómez Medicina Spain Osteopenia Osteoporosis Mass screening Ultrasonography Objectives: To identify postmenopausal women withrisk of osteoporosis through quantitative ultrasoundimaging (QUI) and to value the medical interventionafter the determination of the bone mineral density(BMD).Methods: Cross-sectional descriptive studydeveloped in a community pharmacy. During themonth of June of 2005 the community pharmacyenrolled postmenopausal women into the study.Women in treatment with calcium, vitamin D,hormone replacement therapy, estrogen receptormodulators, calcitonin or biphosphonates wereconsidered criteria for exclusion. To all the womenthat consent to participate, the pharmacistmeasured BMD with the device Sahara HologicUltrasound Bone Densitometer at right calcaneus.Following the World Health Organization, womenwere classified as osteoporotic if their T-Score wasless than -2.5 and as osteopenic if their T-Scoreranged between -2.5 and -1.0.Results: Of the 100 women screened, 11 (11%)presented risk of osteoporosis and 61 (61%) ofosteopenia. The 18.5% postmenopausal womenwith body mass index lesser than 30 presented riskof osteoporosis and the 63.0% osteopenia.Conclusions: The QUI constitutes a useful tool incommunity pharmacy for the screening ofosteoporosis and it supposes a greater integrationof the community pharmacy within the health care. 2006 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69040208 https://www.redalyc.org/journal/690/69040208/ https://www.redalyc.org/journal/690/69040208/html/ https://www.redalyc.org/journal/690/69040208/69040208.epub https://www.redalyc.org/journal/690/69040208/movil en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.2 Vol.4 |
| title | Screening for osteoporosis among postmenopausal women in community pharmacy |
| topic | Medicina Spain Osteopenia Osteoporosis Mass screening Ultrasonography |
| url | https://www.redalyc.org/articulo.oa?id=69040208 https://www.redalyc.org/journal/690/69040208/ https://www.redalyc.org/journal/690/69040208/html/ https://www.redalyc.org/journal/690/69040208/69040208.epub https://www.redalyc.org/journal/690/69040208/movil |